IATROGENIC OSTEOMALACIA IN EPILEPTIC CHILDREN

ABSTRACT: Christiansen, C, Redbro, P., and Theger Nielsen, C. (Departments of Clinical Chemistry, Clinical Physiology, Paediatrics and Neurology, Glostrup Hospital, 2600 Glostrup, and Department of Clinical Physiology, Aalborg Sygehus Syd, 9000 Aalborg, Denmark). Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial. Acta Paediatr Scand, 64:219, 1975.–Bone mineral content (BMC) in the forearms (related to total body calcium) was measured for a controlled therapeutic trial in 25 epileptic children on long‐term treatment with phenytoin and in 22 normal children before and during treatment with vitamin D or placebo. In the epileptic children, hypocalcaemia and elevated serum alkaline phosphatase was found in 20% and 16%, respectively. The group of epileptic children treated with vitamin D2 (2000 IU daily) for 3 months showed a significant increase in bone mineral content, 5% on average. The epileptic children treated with placebo showed a significant decrease, 2% on average, while the normal children treated with vitamin D or placebo showed no change in bone mineral content. The results indicate a possible benefit of prophylactic vitamin D treatment in epileptic children.

[1]  C. Christiansen,et al.  Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia. , 1975, British medical journal.

[2]  C. Christiansen,et al.  INITIAL AND MAINTENANCE DOSES OF VITAMIN D2 IN THE TREATMENT OF ANTICONVULSANT OSTEOMALACIA , 1974, Acta neurologica Scandinavica.

[3]  C. Christiansen,et al.  DEVELOPMENT OF ANTICONVULSANT OSTEOMALACIA IN EPILEPTIC PATIENTS ON PHENYTOIN TREATMENT , 1974, Acta neurologica Scandinavica.

[4]  C. Christiansen,et al.  “Anticonvulsant Action” of Vitamin D in Epileptic Patients? A Controlled Pilot Study , 1974, British medical journal.

[5]  M. Gupta,et al.  Spontaneous cure of vitamin-D deficiency in Asians during summer in Britain. , 1974, Lancet.

[6]  C. Christiansen,et al.  Incidence of Anticonvulsant Osteomalacia and Effect of Vitamin D: Controlled Therapeutic Trial , 1973, British medical journal.

[7]  N. Maclaren,et al.  Vitamin D-dependency Rickets in Institutionalized, Mentally Retarded Children on Long Term Anticonvulsant Therapy. II. The Response to 25-Hydroxycholecalciferol and to Vitamin D2 , 1973, Pediatric Research.

[8]  N. Maclaren,et al.  Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. , 1973, The Journal of pediatrics.

[9]  J. Haddad,et al.  Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. , 1972, The New England journal of medicine.

[10]  D. Rowe,et al.  Plasma Levels and Therapeutic Effect of 25-Hydroxycholecalciferol in Epileptic Patients taking Anticonvulsant Drugs , 1972, British medical journal.

[11]  E. Hvidberg,et al.  Rapid routine determination of some anti-epileptic drugs in serum by gas chromatography. , 1972, Clinica chimica acta; international journal of clinical chemistry.

[12]  J. Hansen,et al.  BONE DENSITY IN PATIENTS RECEIVING LONG‐TERM ANTICONVULSANT THERAPY , 1971, Acta neurologica Scandinavica.

[13]  J. Maxwell,et al.  Altered Calcium Metabolism in Epileptic Children on Anticonvulsants , 1971, British medical journal.

[14]  A. Richens,et al.  Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy , 1970, British medical journal.

[15]  A. Richens,et al.  Disturbance of Calcium Metabolism by Anticonvulsant Drugs , 1970, British medical journal.

[16]  R. Kruse [Osteopathies in antiepileptic long-term therapy (preliminary report)]. , 1968, Monatsschrift fur Kinderheilkunde.

[17]  W. H. Marsh,et al.  Adaptation of an alkaline phosphatase method for automatic colorimetric analysis. , 1959, Clinical chemistry.

[18]  A. B. Hill,et al.  Principles of Medical Statistics , 1950, The Indian Medical Gazette.

[19]  R B Mazess,et al.  Estimation of bone and skeletal weight by direct photon absorptiometry. , 1971, Investigative radiology.